# Clinical Trial to Investigate Therapeutic Vaccine (RUTI) Against Tuberculosis (TB)

> **NCT04919239** · PHASE2 · COMPLETED · sponsor: **Archivel Farma S.L.** · enrollment: 140 (actual)

## Conditions studied

- Tuberculosis, Pulmonary

## Interventions

- **BIOLOGICAL:** RUTI®
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT04919239
- **Lead sponsor:** Archivel Farma S.L.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-22
- **Primary completion:** 2025-06-19
- **Final completion:** 2025-06-19
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2025-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04919239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04919239, "Clinical Trial to Investigate Therapeutic Vaccine (RUTI) Against Tuberculosis (TB)". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT04919239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*